Minor adverse events · adult women with PCOS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surgical site infection · patients undergoing surgery with femoral artery approach
Transverse groin incision may leads to lower surgical site infection (10 to 28 days) compared with vertical groin incision (low certainty).
1 finding from 1 review
Lymphatic complications: Lymphatic leak (28 days) Lymphatic collection (28 days) · patients undergoing surgery with femoral artery approach
It is very uncertain whether transverse groin incision changes lymphatic complications: Lymphatic leak (28 days) Lymphatic… compared with vertical groin incision (very low certainty).
1 finding from 1 review
RR 0.46 [0.2, 1.02]
116 participants
Very low
Graft infection · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prolonged hospitalization (> 1 week) · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reoperative surgery (≤ 30 days; > 30 days) · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurological deficit (e.g. paresthesia) · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether clobetasol propionate 0.05% ointment changes clinical resolution compared with clobetasol propionate 0.025% ointment (very low certainty).
1 finding from 1 review
Pain resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical clobetasol propionate changes pain resolution compared with topical tacrolimus (very low certainty).
1 finding from 1 review
Pain (mean score) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Intralesional betamethasone showed no clear difference in pain (mean score) compared with intralesional triamcinolone acetonide (low certainty).
1 finding from 1 review
Adverse effects · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical clobetasol propionate changes adverse effects compared with topical ciclosporin (very low certainty).
1 finding from 1 review
Adverse events (split-mouth) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Topical triamcinolone acetonide led to lower adverse events (split-mouth) compared with cryotherapy; GRADE not reported.
1 finding from 1 review
Pain (mean score) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
1 finding from 1 review
Pain (mean score) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether clobetasol propionate ointment changes pain (mean score) compared with low-level laser therapy (LLLT) (very low certainty).
1 finding from 1 review
Adverse effects · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical corticosteroid changes adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Clinical score · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Clobetasol propionate 0.025% microspheres showed no clear difference in clinical score compared with clobetasol propionate 0.025% ointment; GRADE not reported.
1 finding from 1 review
Pain resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Topical corticosteroid may leads to higher pain resolution compared with placebo (low certainty).
1 finding from 1 review
Clinical score · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether clobetasol propionate ointment changes clinical score compared with low-level laser therapy (LLLT) (very low certainty).
1 finding from 1 review
Pain (mean score, 0-10) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Topical corticosteroid may leads to lower pain (mean score, 0-10) compared with placebo (low certainty).
1 finding from 1 review